Home Newsfeeds HC Wainwright & Co. Downgrades Vascular Biogenics to Neutral

HC Wainwright & Co. Downgrades Vascular Biogenics to Neutral

HC Wainwright & Co. analyst Swayampakula Ramakanth downgrades Vascular Biogenics (NASDAQ:VBLT) from Buy to Neutral.

byBenzinga Newsdesk

July 20, 2022

1 minute read

HC Wainwright & Co. analyst Swayampakula Ramakanth downgrades Vascular Biogenics (NASDAQ:VBLT) from Buy to Neutral.

Can Ross Stores Keep Up With Retail Giants Target And Walmart? We’ll See At Market Close

By AJ Fabino

February 28, 2:11 PM

As retailers continue to report their earnings for the fourth quarter of 2022, investors are waiting for the upcoming earnings report from Ross Stores (NASDAQ: ROST), which is set to issue its fourth quarter results after market close on Tuesday<

ROST

Reported Earlier, Camtek Receives Orders For 42 Systems From Tier-1 Manufacturers For Heterogeneous Integration, HBM And Fan-Out Applications

By Happy Mohamed

July 13, 9:06 AM

Order momentum increases expectations for a stronger second half of 2023 MIGDAL HAEMEK, Israel, July 13, 2023 /PRNewswire/ -- Camtek Ltd. (NASDAQ:CAMT) (TASE: CAMT), today announced that it has recently

CAMT

NightHawk Biosciences Announces Planned Name Change To Scorpius Holdings, Reflecting Successful Transition To A Large Molecule Biomanufacturing CDMO; In Connection With The Name Change, The Company’s Ticker Will Change To “SCPX”

By Benzinga Newsdesk

January 8, 9:55 AM

NightHawk Biosciences (NYSE:NHWK, NHWK)), an integrated contract development and manufacturing organization (CDMO), today announced that it is changing the name of the Company to Scorpius Holdings, Inc. ("Scorpius") to

NHWK

Illumina And Pillar Biosciences Partner To Improve Access To Personalized Cancer Treatment Options

By Happy Mohamed

July 25, 9:17 AM

Illumina Inc. (NASDAQ:ILMN), a global leader in DNA sequencing and array-based technologies, and Pillar Biosciences Inc., the pioneers of Decision Medicine™, today announced a strategic partnership to make

ILMN

HC Wainwright & Co. Downgrades Vascular Biogenics to Neutral

Related Posts

Can Ross Stores Keep Up With Retail Giants Target And Walmart? We’ll See At Market Close

Reported Earlier, Camtek Receives Orders For 42 Systems From Tier-1 Manufacturers For Heterogeneous Integration, HBM And Fan-Out Applications

NightHawk Biosciences Announces Planned Name Change To Scorpius Holdings, Reflecting Successful Transition To A Large Molecule Biomanufacturing CDMO; In Connection With The Name Change, The Company’s Ticker Will Change To “SCPX”

Illumina And Pillar Biosciences Partner To Improve Access To Personalized Cancer Treatment Options